Ademtech, founded in 2000, is a pioneering company in the arenas of Biotechnology, Life Sciences, Manufacturing, and Medical Devices. Headquartered in France, their focus lies in the development of superparamagnetic nanoparticles for life sciences and in-vitro diagnostics, leveraging groundbreaking research from the CNRS Bordeaux.
The company's technology distinctively produces monodisperse polymer beads with an iron oxide content exceeding 70%, presenting high magnetic properties and specificity for biological applications. These nanoparticles facilitate critical functions like capturing, isolating, and analyzing biological entities such as molecules and viruses.
Beyond their core product offering, Ademtech also provides extensive support through magnetic tools, specialized instruments, and automation systems. Despite the seed investment occurring early in their inception on 01 January 2001, details on subsequent funding are unspecified, presenting a potential opportunity for investment that could bolster growth and market penetration in a rapidly evolving sector.